04:08 AM EDT, 03/20/2025 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said late Wednesday it priced its underwritten public offering of 25 million shares at $2 per share to raise about $50 million in gross proceeds.

The company said it also granted underwriters a 30-day option to purchase up to 3.8 million additional shares at the offering price.

The offering is expected to close on March 21.